Brighter has now received the only remaining approval for consumables related to the Actiste Service from the Saudi Food and Drug Authority (SFDA) in the Kingdom of Saudi Arabia (KSA). The authorization process from the Communications and Information Technology Commission (CITC) for cellular connection is still ongoing. Before the service can be launched in KSA, Brighter will also have to finalize various internal and external go-to-market preparations, e.g. initiate relevant partnerships and ensure local data management compliance.